Drug Name Janssen COVID-19 Vaccine Drug Class Risk minimization type Direct Healthcare Professional Communication DHPC Specialty (Theraputic area) Risk COVID-19 Vaccine Janssen: Contraindication in individuals with previous capillary leak syndrome and update on thrombosis with thrombocytopenia syndrome Dear Healthcare provider letter DHPC